After Long Regulatory Run, Sanofi’s Dupixent Set To Transform India AD Market

 
• By Anju Ghangurde
  
Sanofi's dupilumab set for India debut • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip